- Details
- Description
Packaging Size:
50Capsule
Strength:
150mg
Composition:
Ceritinib
Treatment:
ALK positive metastatic NSCLC
Form:
Capsule
Brand:
Cerini
Quantity Unit:
150mg*50C
Manufacturer:
Tongmeng (Lao) Pharmaceutical & Food Co., Ltd.（TLPH）
Ceritinib is a prescription-only drug used for the treatment of non-small cell lung cancer (NSCLC).
Non-Small Cell Lung Cancer
Indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test 450 mg PO qDay with food Continue until disease progression or unacceptable toxicity Also see administrationDosage Modifications
Dose reduction increments
- Starting dose: 450 mg qDay
- First dose reduction: 300 mg qDay
- Second dose reduction: 150 mg qDay
- Unable to tolerate 150 mg/day: Discontinue
